The Effect of Creatine Supplementation on Muscle Loss During Immobilisation

The Effect of Creatine Supplementation on Muscle Loss During Immobilisation - Creatine and disuse atrophy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON40238

Enrollment

Registered

2013-08-28

Start date

2013-09-25

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disuse atrophy

Interventions

One leg will be immobilized at a 30 degree knee joint angle of flexion for 7 days by means of a full leg cast. In addition, participants will ad random be allocated to the creatine group or placebo

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male Aged from 18-35 years 18.5

Exclusion criteria

Exclusion criteria: (Family) history of thrombosis Smoking Recent surgery

Design outcomes

Primary

Measure	Time frame
quadriceps muscle CSA	—

Secondary

Measure	Time frame
whole upper leg muscle CSA muscle fiber type specific CSA muscle fiber type-specific satellite cell content 1RM muscle strength	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)